[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340860-105":59,"doc-detail-340860-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cdc6-may-serve-as-an-indicator-of-lung-adenocarcinoma-prognosis-and-progression-based-on-tcga-and-geo-data-mining-and-experimental-analyses","CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses","","Lung adenocarcinoma (LUAD) is a highly lethal cancer, making reliable prognosis prediction a major clinical challenge. This study integrated tissue sequencing and patient clinical information from TCGA and GEO using bioinformatics to identify 252 differentially expressed genes. Univariate and multivariate Cox analyses selected 14 and 3 genes, including CDC6, for two prognostic models. The 3-gene model matched the 14-gene model’s predictive ability. Enrichment indicated CDC6 regulates the cell cycle and promotes tumor staging, while CDC6 downregulation suppressed migration, invasion, and proliferation in vitro and reduced tumor burden and metastasis in vivo. Findings support CDC6 as a critical prognostic marker for personalized LUAD management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cdc6-may-serve-as-an-indicator-of-lung-adenocarcinoma-prognosis-and-progression-based-on-tcga-and-geo-data-mining-and-experimental-analyses/340860/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cdc6-may-serve-as-an-indicator-of-lung-adenocarcinoma-prognosis-and-progression-based-on-tcga-and-geo-data-mining-and-experimental-analyses/340860.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were prognostic gene models constructed in this study?","Question",{"text":112,"@type":113},"The study used bioinformatics to identify differentially expressed genes from LUAD datasets in TCGA and GEO, then applied univariate and multivariate Cox analyses to select genes for prognostic models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What genes were selected for the final prognostic models?",{"text":117,"@type":113},"Two models were built: one using 14 genes and another using 3 genes, which included CDC6, hyaluronan mediated motility receptor, and STIL centriolar assembly protein.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence links CDC6 to LUAD progression?",{"text":121,"@type":113},"In vitro downregulation of CDC6 inhibited tumor cell migration, invasion, and proliferation. In vivo, downregulating CDC6 reduced in situ lung tumor burden and metastasis in mice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340860,1790146444,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","ONCOLOGY REPORTS 51: 35, 2024  \nCDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses  \nHAO LOU 1 , ZELAI WU2 and GUANGYOU WEI 1,3,4  \n1School of Medicine, Anhui University of Science and Technology, Huainan, Anhui 232001; 2Department of Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058; 3Department of Pediatrics, Bozhou Municipal People's Hospital; 4Department of Pediatrics, Bozhou Clinical Medicine of Anhui University of Science and Technology School, Bozhou, Anhui 236800, P.R. China  \nReceived August 1, 2023; Accepted November 29, 2023  \nDOI: 10. 3892/or.2024.8694  \nAbstract. Lung adenocarcinoma (LUAD) is one of the most lethal types of cancer worldwide, and accurately predicting patient prognosis is an important challenge. Gene prediction models, which are known for their simplicity and efficiency, have the potential to be used for prognostic predictions . However, the availability of models with true clinical value is limited. The present study integrated tissue sequencing and the clinical information of patients with LUAD from The Cancer Genome Atlas and Gene Expression Omnibus databases using bioinformatics. This comprehensive approach enabled the identification of 252 differentially expressed genes. Subsequently, univariate and multivariate Cox analyses were performed using these genes, and 14 and 3 genes [including cell division cycle 6 (CDC6), hyaluronan medi‑ ated motility receptor and STIL centriolar assembly protein] were selected for the construction of two prognostic models. Notably, the 3‑gene prognostic model exhibited a comparable predictive ability to that of the 14‑gene model. Functionally, pathway enrichment analysis revealed that CDC6 played a role in regulating the cell cycle and promoting tumor staging. To further investigate the relevance of CDC6, in vitro experi‑ ments involving the downregulation of CDC6 expression were conducted, which resulted in significant inhibition of tumor cell migration, invasion and proliferation. Moreover, in vivo experiments demonstrated that downregulating CDC6 expres‑ sion significantly reduced the burden and metastasis of in situ lung tumors in mice. These findings suggested that CDC6 maybe a critical gene involved in the development and prognosis of  \nCorrespondence to: Professor Guangyou Wei, School of Medicine, Anhui University of Science and Technology, 168 Taifeng Street, Huainan, Anhui 232001, P.R. China  \nE‑mail: [13515682626@163.com](13515682626@163.com)  \nKey words: lung adenocarcinoma, CDC6, prognostic model, cell cycle  \nLUAD. In summary, the present study successfully constructed a simple yet accurate prognostic prediction model consisting of 3 genes. Additionally, the functional importance of CDC6 as a key gene in the model was identified. These findings lay a crucial foundation for further exploration of prognostic predic‑ tion models and a deeper understanding of the functional mechanisms of CDC6 . Notably, these results have potential clinical implications for improving personalized treatment and prognosis evaluation for patients with LUAD.  \nIntroduction  \nLung cancer is the most common cause of cancer‑associated mortalities worldwide (1) . The majority of cases (>85%) are classified as non‑small cell lung cancer (NSCLC), with lung adenocarcinoma (LUAD) being the prevailing clinico‑ pathological type (2) . Despite important advancements in the diagnosis and treatment of lung cancer over the last few decades, the 5‑year relative survival rate for patients with lung cancer is only 18%(3) . Currently, diagnosing lung cancer mainly relies on histopathological examination, tumor molecular biological markers and imaging evaluation, which makes early detection and diagnosis challenging (4,5) . This difficulty in early detection and diagnosis may explain the high mortality rate of this disease. Therefore, it is crucial to ","cbCaimDgSiloSDwh","https://ap.wps.com/l/cbCaimDgSiloSDwh","pdf",14829907,17,"English","# Abstract\n# Introduction\n## Lung cancer burden and clinical challenge\n## Differentially expressed genes and key oncogenic roles\n## Study design: TCGA/GEO analysis and experimental validation","[{\"question\":\"How were prognostic gene models constructed in this study?\",\"answer\":\"The study used bioinformatics to identify differentially expressed genes from LUAD datasets in TCGA and GEO, then applied univariate and multivariate Cox analyses to select genes for prognostic models.\"},{\"question\":\"What genes were selected for the final prognostic models?\",\"answer\":\"Two models were built: one using 14 genes and another using 3 genes, which included CDC6, hyaluronan mediated motility receptor, and STIL centriolar assembly protein.\"},{\"question\":\"What experimental evidence links CDC6 to LUAD progression?\",\"answer\":\"In vitro downregulation of CDC6 inhibited tumor cell migration, invasion, and proliferation. In vivo, downregulating CDC6 reduced in situ lung tumor burden and metastasis in mice.\"}]","CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses | PDF",1790039214,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/948feb4b0c95c453e2d8568370d65577.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64b065818dadc0b8148c7dc2fc6c32fe.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0118f13cdcc241bc52802d3a5908fb2.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4b01e4e96f1e5be88a8d79e993394ec.webp",980,1353]